Literature DB >> 7741164

Endemic kala-azar in eastern Sudan: post-kala-azar dermal leishmaniasis.

E E Zijlstra1, A M el-Hassan, A Ismael.   

Abstract

In a longitudinal study between 1991 and 1993 in an endemic area in eastern Sudan, 85 cases of kala-azar (visceral leishmaniasis) were diagnosed, of whom 48 (56%) developed post-kala-azar dermal leishmaniasis (PKDL). Another four cases of PKDL had no clinical history of kala-azar. In children, PKDL was more frequent in the very young; seven of nine kala-azar cases (78%) in the group 0-1 years of age and 13 of 16 (81%) in the group 2-3 years of age developed PKDL. On the average, PKDL occurred 56 days (mean; range 0-180) after the end of treatment of kala-azar. To assess the severity of PKDL, a classification was developed using three grades of severity based on differences in density and distribution of lesions. In young children, PKDL was more severe. Incomplete treatment of kala-azar may be important in the pathogenesis of PKDL. Thirty-one patients were followed-up for at least six months; of these, 20 were not treated (17 healed, two improved, and in one, the condition was unchanged), three healed after incomplete treatment with sodium stibogluconate, and eight were cured after treatment but two required two courses. Considerable morbidity was caused by PKDL and should be taken into consideration in the management and follow-up of kala-azar patients. The high incidence of PKDL may have important implications in transmission.

Entities:  

Mesh:

Year:  1995        PMID: 7741164     DOI: 10.4269/ajtmh.1995.52.299

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  20 in total

Review 1.  Laboratory diagnosis of visceral leishmaniasis.

Authors:  Shyam Sundar; M Rai
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

Review 2.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

3.  High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis.

Authors:  S Gasim; A M Elhassan; E A Khalil; A Ismail; A M Kadaru; A Kharazmi; T G Theander
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

4.  The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC).

Authors:  S Gasim; A M Elhassan; A Kharazmi; E A Khalil; A Ismail; T G Theander
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

5.  Effect of ambient temperature on the clinical manifestations of experimental diffuse cutaneous leishmaniasis in a rodent model.

Authors:  Laura Quiñonez-Díaz; Javier Mancilla-Ramírez; Miroslava Avila-García; Juana Ortiz-Avalos; Angélica Berron; Susana González; Yuriria Paredes; Norma Galindo-Sevilla
Journal:  Vector Borne Zoonotic Dis       Date:  2012-05-31       Impact factor: 2.133

6.  rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection.

Authors:  E E Zijlstra; N S Daifalla; P A Kager; E A Khalil; A M El-Hassan; S G Reed; H W Ghalib
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

7.  Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.

Authors:  Samiran Saha; Tuhina Mazumdar; Khairul Anam; Rajesh Ravindran; Bibhas Bairagi; Bibhuti Saha; Ramapada Goswami; Netai Pramanik; Subhashis K Guha; Sourjya Kar; Dwijadas Banerjee; Nahid Ali
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

8.  Use of PCR for diagnosis of post-kala-azar dermal leishmaniasis.

Authors:  O F Osman; L Oskam; N C Kroon; G J Schoone; E T Khalil; A M El-Hassan; E E Zijlstra; P A Kager
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh.

Authors:  Shamim Islam; Eben Kenah; Mohammed Ashraful Alam Bhuiyan; Kazi Mizanur Rahman; Brook Goodhew; Chowdhury Mohammad Ghalib; M M Zahid; Masayo Ozaki; M W Rahman; Rashidul Haque; Stephen P Luby; James H Maguire; Diana Martin; Caryn Bern
Journal:  Am J Trop Med Hyg       Date:  2013-07-01       Impact factor: 2.345

10.  Genetic and functional evaluation of the role of DLL1 in susceptibility to visceral leishmaniasis in India.

Authors:  Sanjana Mehrotra; Michaela Fakiola; Anshuman Mishra; Medhavi Sudarshan; Puja Tiwary; Deepa Selvi Rani; Kumarasamy Thangaraj; Madhukar Rai; Shyam Sundar; Jenefer M Blackwell
Journal:  Infect Genet Evol       Date:  2012-04-24       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.